Document is current
Any future updates will be listed below
-
Authors
Ahmed, Sabbir
Sparidans, Rolf W.
Vernooij, Robin W. M.
Mihaila, Silvia M.
Broekhuizen, Roel
Goldschmeding, Roel
Nguyen, Tri Q.
Masereeuw, Rosalinde
Gerritsen, Karin G. F.
-
Funding
Funding for this research was provided by:
Dutch Kidney Foundation (Kolff+ program (DETOX; 22OK1019), CP1805 “TASKFORCE”, CP1805 “TASKFORCE”, Kolff+ program (DETOX; 22OK1019), Kolff+ program (DETOX; 22OK1019))
European Commission (KIDNEW, HORIZON-EIC-2022 Pathfinder program, grant agreement no. 101099092, KIDNEW, HORIZON-EIC-2022 Pathfinder program, grant agreement no. 101099092)
European Union’s Horizon 2020 research and innovation programme (Marie Skłodowska-Curie grant agreement No 813839, Marie Skłodowska-Curie grant agreement No 813839)
a public-private partnership between the American Society of Nephrology (ASN) and the US Department of Health and Human Services (KidneyX (MI-TRAM), KidneyX (MI-TRAM))
- License Information
-
More Information
Article History
Received: 16 March 2025
Accepted: 13 June 2025
First Online: 2 July 2025
Declarations
:
: The authors declare no competing interests.
: The clinical study was registered in the Netherlands Trial Register (NTR 4439), complied with the Declaration of Helsinki and Good Clinical Practice Guidelines, and was approved by the Medical Ethics Committee of the University Medical Center Groningen, the Netherlands (METc 2014/111) (28). All participants (N = 33) provided written informed consent before any study procedure started. All animal experiments were performed with the approval of the Experimental Animal Ethics Committee of the University of Utrecht (DEC number 2009.II.11.129).
